Table 5.
Patient Characteristics at ED Presentation by Risk Profile: Training Cohort (NYP-WCM).
| Early deterioration |
Late deterioration |
No deterioration |
|
|---|---|---|---|
| (N = 105) | (N = 626) | (N = 314) | |
| Demographics | |||
| Age | |||
| >=65 | 68 (64.8%) | 369 (58.9%) | 114 (36.3%) |
| Race | |||
| White | 39 (37.1%) | 241 (38.5%) | 120 (38.2%) |
| Black | 12 (11.4%) | 89 (14.2%) | 43 (13.7%) |
| Asian | 7 (6.7%) | 72 (11.5%) | 30 (9.6%) |
| Other | 26 (24.8%) | 121 (19.3%) | 73 (23.2%) |
| Not Specified | 21 (20.0%) | 103 (16.5%) | 48 (15.3%) |
| Sex | |||
| Male | 63 (60.0%) | 395 (63.1%) | 164 (52.2%) |
| BMI (kg/m^2) | |||
| <25 | 34 (32.4%) | 228 (36.4%) | 89 (28.3%) |
| 25 to <30 | 29 (27.6%) | 202 (32.3%) | 116 (36.9%) |
| >=30 | 40 (38.1%) | 187 (29.9%) | 105 (33.4%) |
| Missing | 2 (1.9%) | 9 (1.4%) | 4 (1.3%) |
| Active and/or former smoker/vaper | 37 (35.2%) | 184 (29.4%) | 74 (23.6%) |
| ED Supplemental Oxygen | |||
| Required supplemental oxygen within the first 3 h of arrival | 88 (83.8%) | 365 (58.3%) | 123 (39.2%) |
| Comorbidities | |||
| Diabetes Mellitus (DMI, DMII) | 38 (36.2%) | 206 (32.9%) | 77 (24.5%) |
| Hypertension (HTN) | 67 (63.8%) | 390 (62.3%) | 137 (43.6%) |
| Chronic Obstructive Pulmonary Disease (COPD) | 8 (7.6%) | 36 (5.8%) | 7 (2.2%) |
| Chronic Kidney Disease (CKD) | 6 (5.7%) | 38 (6.1%) | 7 (2.2%) |
| End Stage Renal Disease (ESRD) | 4 (3.8%) | 55 (8.8%) | 14 (4.5%) |
| Coronary Artery Disease (CAD) | 24 (22.9%) | 108 (17.3%) | 25 (8.0%) |
| Any Cancer | 8 (7.6%) | 59 (9.4%) | 18 (5.7%) |
| Any Immunosuppression | 3 (2.9%) | 24 (3.8%) | 8 (2.5%) |
| Symptoms | |||
| Fever | 77 (73.3%) | 433 (69.2%) | 224 (71.3%) |
| Cough | 72 (68.6%) | 432 (69.0%) | 220 (70.1%) |
| Diarrhea | 29 (27.6%) | 161 (25.7%) | 89 (28.3%) |
| Nausea or vomiting | 16 (15.2%) | 103 (16.5%) | 83 (26.4%) |
| Myalgias | 22 (21.0%) | 123 (19.6%) | 73 (23.2%) |
| Dyspnea | 80 (76.2%) | 415 (66.3%) | 188 (59.9%) |
| Initial Chest X-ray Findings | |||
| Unilateral Infiltrate | 9 (8.6%) | 80 (12.8%) | 21 (6.7%) |
| Bilateral Infiltrates | 90 (85.7%) | 454 (72.5%) | 220 (70.1%) |
| Pleural Effusion | 10 (9.5%) | 38 (6.1%) | 9 (2.9%) |
| Other | 5 (4.8%) | 36 (5.8%) | 17 (5.4%) |
| Outcome | |||
| Intubation and/or in-hospital mortality | 86 (81.9%) | 195 (31.2%) | 14 (4.5%) |